Study at a glance
What question did the studies ask?
Does giving vitamin D during serious illness improve recovery or restore immune function? Studies included critically ill adults, hospitalised COVID-19 patients and a small trial in sepsis, a serious illness involving a harmful response to infection. Another study used existing patient records to examine persistent symptoms months after infection.
What did they find?
The larger hospital trials did not establish their main recovery or survival benefits, even when blood vitamin D rose. The small sepsis study found selected biological changes. Some comparisons using existing patient records suggested fewer persistent symptoms, but could not establish causation.
What does this mean?
A changed blood test or immune marker does not by itself show that a patient recovers faster or that the whole immune system works better.
What are the limits?
Large doses given during illness differ from vitamin D status before illness. Small groups, uncertain secondary findings and differences between patients limit conclusions. Research treatments are not personal dosing instructions. The evidence does not establish a general immune-recovery benefit.
Read the full article below ↓Raising blood vitamin D during serious illness did not reliably improve the main recovery outcomes in the assessed trials. A small sepsis study found changes in selected biological measurements, but that did not prove better recovery. A later study using existing patient records found an uncertain association with persistent symptoms. Read the detailed review, Vitamin D, Serious-Illness Recovery and the Limits of Immune Resilience Claims: Full Evidence Review.
What did the hospital trials test?
VITdAL-ICU compared vitamin D3 treatment with placebo in critically ill adults with low vitamin D. It did not establish a shorter hospital stay or an overall survival benefit. A favourable result in the subgroup with more severe deficiency was less secure than the main trial result.
VIOLET then tested an early large vitamin D3 dose in a larger group of deficient critically ill patients. It did not demonstrate better survival at 90 days. Death occurred in 23.5% of the vitamin D group and 20.6% of the placebo group among participants with available follow-up. The uncertainty around that difference did not establish benefit or prove that every treatment schedule causes harm.
A Brazilian trial in hospitalised COVID-19 patients also raised blood vitamin D without establishing earlier discharge. Median hospital stay was seven days in both groups. These trials tested treatment during established illness; they did not test every possible exposure before illness began.
What did the smaller sepsis study show?
Sepsis is a serious illness involving a harmful response to infection. A trial of 30 patients found changes in vitamin D and an antimicrobial peptide, a small protein involved in defence. The study was too small and limited to establish restored immune function or better clinical recovery. Early defence is introduced in Vitamin D and Innate Immunity.
What about symptoms lasting months?
A study of 132 endocrine outpatients examined vitamin D supplementation and persistent symptoms six months after infection. Some comparisons that allowed for measured differences between groups favoured supplementation, but the initial comparison was uncertain. Because treatment was not randomly assigned, differences in health and behaviour could help explain the result. The study did not directly measure immune recovery.
What does this mean?
A changed blood test does not necessarily mean that a person recovers faster. Leaving hospital, surviving illness and regaining immune function are related but different outcomes. Vitamin D and Systemic Resilience explains the wider idea of recovery across body systems, while Vitamin D and Immune Modulation introduces immune regulation.
The evidence does not establish a general recovery benefit from extra vitamin D during serious illness. The very large doses used in some trials are research treatments, not instructions for personal use. The findings should remain attached to the specific patients, treatment schedules and outcomes studied.
Sources
Related reading
Vitamin D, Serious-Illness Recovery and the Limits of Immune Resilience Claims: Full Evidence Review
Critical-care, sepsis and COVID-19 studies distinguish vitamin D changes from recovery, survival and proof of restored immune function.
Read more →Resistance, Recovery and Immune Resilience: Reading the Outcomes
Learn why symptom scores, infection counts, immune markers and hospital recovery measure different things in vitamin D research.
Read more →Evaluation of serum vitamin D levels in COVID-19 positive critically ill adults
Mean ± SD serum 25(OH)D levels amongst the study participants were 48.5 ± 27.7 nmol/L.
Original paper ↗Read more →Vitamin D and Immune Resilience
Learn how vitamin D contributes to immune resilience by supporting balanced activation, adaptation to challenges, and efficient recovery through coordinated physiological networks.
Read more →Effective food hygiene principles and dietary intakes to reinforce the immune system for prevention of COVID-19: a systematic review
This study aimed at reviewing effective food hygiene principles and dietary intakes to reinforce the immune system for prevention of corona virus disease 2019 (COVID-19).
Original paper ↗Read more →Impact of the COVID-19 pandemic on growth, nutrition and immune function in infants and toddlers
Pre-pandemic (2017 to 2018) and pandemic (2021 to 2023) cohorts were compared.
Original paper ↗Read more →Suboptimal Consumption of Relevant Immune System Micronutrients Is Associated with a Worse Impact of COVID-19 in Spanish Populations
Coronavirus disease 2019 (COVID-19) has caused a global health crisis and the factors behind its differential impact on COVID-19 among populations are still being known.
Original paper ↗Read more →The Role of Vitamin C, Vitamin D, and Selenium in Immune System against COVID-19
Low levels of micronutrients have been associated with adverse clinical outcomes during viral infections.
Original paper ↗Read more →Vitamin D regulation of immune function during covid-19
Whether such will be the case for SARS-CoV2 remains to be seen, but is currently being proposed and investigated.
Original paper ↗Read more →Effect of test-and-treat vitamin D supplementation on SARS-CoV-2 vaccine efficacy and immunogenicity (CORONAVIT; Jolliffe et al., 2022): Full Evidence Review
Detailed analysis of a randomized controlled trial examining vitamin D supplementation and its effects on SARS-CoV-2 vaccine immunogenicity and efficacy in adults with sub-optimal vitamin D status.
Read more →Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers
The objective of current study is to analyze the vitamin D level in COVID-19 patients and its impact on the disease severity.
Original paper ↗Read more →Determinants of severity among hospitalised COVID-19 patients: Hospital-based case-control study, India, 2020
Risk factors for the development of severe COVID-19 disease and death have been widely reported across several studies.
Original paper ↗Read more →Epidemiology, outcomes, and utilization of intensive care unit resources for critically ill COVID-19 patients in Libya: A prospective multi-center cohort study
This study aimed to determine the mortality and morbidity of COVID-19 patients in intensive care units (ICU) following 60 days after ICU admission, and explore the factors that influence in‐ICU mortality rate.
Original paper ↗Read more →Investigating the Relationship between Vitamin D and Persistent Symptoms Following SARS-CoV-2 Infection
The emergence of persistent symptoms following SARS-CoV-2 infection, known as long COVID, is providing a new challenge to healthcare systems.
Original paper ↗Read more →Micronutrient Status of Critically Ill Patients with COVID-19 Pneumonia
Micronutrient deficiencies can develop in critically ill patients, arising from factors such as decreased intake, increased losses, drug interactions, and hypermetabolism.
Original paper ↗Read more →Vitamin D Status and the Risk for Hospital-Acquired Infections in Critically Ill Adults: A Prospective Cohort Study
To identify patient characteristics associated with low serum 25-hydroxyvitamin D (25(OH)D) concentrations in the medical intensive care unit (ICU) and examine the relationship between serum 25(OH)D and the risk for hospital-acquired infections.
Original paper ↗Read more →Vitamin D and Immune Robustness During Repeated Respiratory Challenges: Full Evidence Review
Trials of vitamin D during recurrent respiratory illness, older adulthood and training stress: benefits, null findings, falls and measurement limits.
Read more →Vitamin D and Immune Robustness During Repeated Respiratory Challenges: Study Summary
A clear summary of respiratory studies: some small trials found benefits, larger trials were null, and one older-adult trial reported more falls.
Read more →Immune Response to Vaccination against COVID-19 at Different Second-Dose Intervals and Their Associations with Metabolic Parameters
Thus, we aimed to assess whether the metabolic status of individuals affects their humoral immune responses to the vaccination.
Original paper ↗Read more →Increased complications of proximal femur fractures during the COVID-19 pandemic: a nationwide medical claims database study in Japan
The proximal femur fractures undergoing surgery during the COVID-19 pandemic or countermeasure period were compared with the pre-pandemic in a Japanese national inpatient data.
Original paper ↗Read more →Vitamin D Status and Immune Response in Hospitalized Patients with Moderate and Severe COVID-19
The frequency of CD3+CD4+ T helper (Th) cells was decreased in patients with 25(OH)D level ≤ 11.4 ng/mL, compared to healthy controls (HCs).
Original paper ↗Read more →Original sources
Early High-Dose Vitamin D3 for Critically Ill, Vitamin D–Deficient Patients
Ginde et al., for the VIOLET investigators (2019).
Publication details
Ginde et al., for the VIOLET investigators (2019). Early High-Dose Vitamin D3 for Critically Ill, Vitamin D: Deficient Patients. The New England journal of medicine. 381(26):2529 to 2540. DOI: 10.1056/NEJMoa1911124.
Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial
Published in JAMA. 2021;325(11):1053 to 1060. DOI: 10.1001/jama (2020).
Publication details
Murai et al. (2021). Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial. JAMA. 2021;325(11):1053 to 1060. DOI: 10.1001/jama.2020.26848.
Effect of cholecalciferol supplementation on vitamin D status and cathelicidin levels in sepsis: A randomized, placebo-controlled trial
Quraishi et al. (2015).
Publication details
Quraishi et al. (2015). Effect of cholecalciferol supplementation on vitamin D status and cathelicidin levels in sepsis: A randomized, placebo-controlled trial. Critical care medicine. 43(9):1928 to 1937. DOI: 10.1097/CCM.0000000000001148.
Effect of High-Dose Vitamin D3 on Hospital Length of Stay in Critically Ill Patients With Vitamin D Deficiency: The VITdAL-ICU Randomized Clinical Trial
Published in JAMA. 312(15):1520-1530. DOI: 10.1001/jama (2014).
Publication details
Amrein et al. (2014). Effect of High-Dose Vitamin D3 on Hospital Length of Stay in Critically Ill Patients With Vitamin D Deficiency: The VITdAL-ICU Randomized Clinical Trial. JAMA. 312(15):1520-1530. DOI: 10.1001/jama.2014.13204.
Typographical Errors
Published in JAMA. 312(18):1932. Correction. DOI: 10.1001/jama (2014).
Publication details
JAMA (2014). Typographical Errors. JAMA. 312(18):1932. Correction. DOI: 10.1001/jama.2014.14740.
Chronic cholecalciferol supplementation and adequate vitamin D status are associated with reduced risk of Long COVID
Di Filippo et al. (2026).
Publication details
Di Filippo et al. (2026). Chronic cholecalciferol supplementation and adequate vitamin D status are associated with reduced risk of Long COVID. Journal of endocrinological investigation. 49(8):1955-1969. DOI: 10.1007/s40618-026-02858-8.